vitamin cash - all about REITs
Pavreit 3Q2014 report, 突破52weeks新高
investfuture
Publish date: Sat, 01 Nov 2014, 08:21 AM
Pavreit(5212)股价屡创新高，于2014年10月的最后一个交易日收在RM1.50，52weeks新高！Pavreit优异的季度报告无疑是股价屡创新高的功臣之一。
看看pavreit 3Q2014 季度报告：
revenue 从RM93,204,000上涨至RM101,432,000,上涨RM8,228,000或 8.8%
profit则从RM52,949,000上涨至RM63,027,上涨了RM10,078,000或19%
与Igbreit不同的是，pavreit的profit确确实实的上涨了19% 这当中并没有任何的Unrealised income (例如：change in fair value of investment property) pavreit 表示，profit的上涨归功于1）更新租约提升租金 2）上半年产业估值过高回退 3）其中一个TNB电表估值过高回退
虽然管理层并没提及，但是依uncle看来，之前pavreit所提及并且已经完成扩建的extra retail space相信已经开始贡献收益，有兴趣看久闻的朋友请click here
值得注意的是，虽然pavreit的revenue上涨8.8% 但其实涨幅都是由pavilion shopping mall提供，pavilion tower表现得比去年同季度差，看图下：
虽然pavreit交出漂亮的成绩单，但是管理层表示将会慎重看待2015年的挑战，毕竟明年即将实施的消费税和津贴合理化预计将会影响大马retail市场。
想更了解pavreit? 请click here连接到pavreit detail
謝謝你的瀏覽，如果你覺得malaysiareit.com不錯，請在blog的右上角給我們的facebook page一個like或到malaysiareit tracker(click here) register 您的資料， 讓我們update您最新消息。
謝謝你的瀏覽，如果你覺得malaysiareit.com不錯，請在blog的右上角給我們的facebook page一個like或到malaysiareit tracker(click here) register 您的資料， 讓我們update您最新消息。
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on vitamin cash - all about REITs
Hektar 3Q2020 quarter report analysis, big dividend distribute soon
Created by investfuture | Dec 11, 2020
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-11-22 16:35:00
ADX
5 Mins
BUY
2024-11-22 16:30:00
EMA 5
5 Mins
BUY
2024-11-22 16:30:00
MACD/RSI
5 Mins
BUY
2024-11-22 16:00:00
ADX
30 Mins
BUY
2024-11-22 15:10:00
EMA 5
5 Mins
SELL
Apps
Top Articles
1
Good Articles to Share
2
3
Mercury Securities Research
4
Koon Yew Yin's Blog
5
BFM Podcast
6
BFM Podcast
7
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
